IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.8

Change

+0.36 (+1.11)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.03 (+0.13%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.19 (+0.32%)

USD 35.71B
DFAC Dimensional U.S. Core Equity 2..

+0.19 (+0.56%)

USD 30.37B
DTB DTE Energy Company 2020 Series

-0.01 (-0.05%)

USD 26.58B
VRGWX Vanguard Russell 1000 Growth I..

+0.40 (+0.05%)

USD 26.28B
JPST JPMorgan Ultra-Short Income ET..

-0.01 (-0.02%)

USD 25.99B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 25.64B
GBTC Grayscale Bitcoin Trust (BTC)

+1.24 (+2.47%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+0.55 (+0.58%)

USD 13.60B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 12.46B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.92% 46% F 51% F
Dividend Return 0.88% 26% F 18% F
Total Return 9.80% 44% F 46% F
Trailing 12 Months  
Capital Gain 22.67% 60% D- 63% D
Dividend Return 0.99% 19% F 13% F
Total Return 23.66% 57% F 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.71% 73% C 55% F
Dividend Return 5.04% 70% C- 48% F
Total Return 0.33% 19% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 7.08% 64% D 85% B
Risk Adjusted Return 71.14% 82% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.